OCT 19, 2017 5:55 AM PDT

Scientists Discover "Block-and-Lock" Drug to Cure HIV

WRITTEN BY: Kara Marker

For the first time, researchers dare to suggest they may have found a functional cure for HIV, the viral infection that leads to AIDS: a new drug used in combination with existing antiretroviral treatment stops HIV in its tracks. The remarkable study describing this discovery was recently published in the journal Cell Reports.

Scanning electron micrograph of HIV-1 budding (in green) from cultured lymphocyte. Credit: CDC

From the Scripps Research Institute, scientists introduce a derivative of a natural compound called didehydro-Cortistatin A (dCA). The dCA derivative works by blocking a transcriptional activator called Tat in virally-infected cells. Without Tat, viruses can’t replicate. If viruses can’t replicate, they can’t cause disease.

According to study leader Susana Valente, this is the first-ever treatment approach to completely halt viral production in infected cells.

"This is the only class of drugs that stops infected cells from making viruses outright," Valente explained. "All current antivirals work later in the viral lifecycle, so only a HIV transcriptional inhibitor like dCA can stop the side effects of low-level virus production."

The new drugs works as a “Block-and-Lock” approach. It prevents latent viruses from “waking up” and causing future infection. And why combine it with existing antiretroviral drugs? "Combining dCA with anti-retroviral therapy accelerates HIV-1 suppression and prevents viral rebound after treatment interruption, even during strong cellular activation," Valente explained.

HIV is infamous for hiding in cells, remaining dormant until treatment stops, only to resurface and cause an infection even worse than before. The new drug stops the resurfacing, and in new studies applying the maximum tolerable dose of the drug, Valente sees “virtually no side effects.”

Researchers from the SRI tested the new combination therapy in a mouse model of a latent and persistent HIV infection. Mice were given one month of treatment, and latent viruses continued to be “blocked and locked” for 19 days after treatment stopped. To put things into perspective, for mice who only received antiretroviral drugs, the virus “came back to life” within a week of the drugs stopping.

"This study shows that a 'functional cure' approach can succeed in reducing residual virus in the blood during anti-retroviral treatment and limiting viral rebound during treatment interruption,” explained co-first author Cari F. Kessing.

The results Valente and her team saw were promising given the treatment was only administered for a month. But what could the benefits be when treatment continued for a longer period of time?

“The question is, how long?” Valente said. “We're studying that now."

Source: Scripps Research Institute

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
AUG 29, 2021
Cardiology
Bystanders Can Help Cardiac Arrest Victims Survive
AUG 29, 2021
Bystanders Can Help Cardiac Arrest Victims Survive
New research has indicated that if someone is having a heart attack, a swift response from anyone that might be nearby c ...
AUG 30, 2021
Health & Medicine
For the love of java: Researchers find association, not causation, between excessive coffee consumption, brain size, and dementia
AUG 30, 2021
For the love of java: Researchers find association, not causation, between excessive coffee consumption, brain size, and dementia
Researchers find association, not causation, between excessive coffee consumption, brain size, and dementia
SEP 09, 2021
Cancer
Can a Mole Fight Melanoma?
SEP 09, 2021
Can a Mole Fight Melanoma?
About 30% of melanoma cases arise from an existing nevus.  More commonly known as moles, Nevi are skin growths that ...
SEP 06, 2021
Drug Discovery & Development
Antibiotics Increase Colon Cancer Risk by 17%
SEP 06, 2021
Antibiotics Increase Colon Cancer Risk by 17%
People who take antibiotics are at an increased risk of developing colon cancer within five to ten years. The research w ...
SEP 13, 2021
Health & Medicine
How Farming Shaped the Immune System
SEP 13, 2021
How Farming Shaped the Immune System
In today's society, a rural upbringing is associated with a healthier immune system less prone to allergies and auto ...
SEP 14, 2021
Technology
Dental Implant Produces Its Own Electricity And Fights Bacteria
SEP 14, 2021
Dental Implant Produces Its Own Electricity And Fights Bacteria
The use of dental implants offers a long term, effective treatment approach for lost or missing teeth compared to method ...
Loading Comments...